NCT00823290 2020-12-14Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC)University of Erlangen-Nürnberg Medical SchoolPhase 1 Terminated2 enrolled
NCT00873002 2012-03-20Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by SurgeryCase Comprehensive Cancer CenterPhase 1 Terminated3 enrolled